New Delhi: As of June 30, 2024, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) has authorized 7.37 crore hospital admissions totalling ₹1 lakh crore, according to the latest data from the Ministry of Health. The scheme is active across 33 states and Union Territories.
According to an IANS report, the leading states in which Ayushman cards have been created under the PMJAY scheme include Madhya Pradesh with 402.5 lakh cards, Maharashtra (280 lakh), Karnataka (171.5 lakh) Jammu and Kashmir (85.9 lakh), Telangana (82.5 lakh), Tamil Nadu (73.6 lakh) and Meghalaya (19.76 lakh).
Also Read:Ayushman Bhav Campaign: Delhi AIIMS to deploy Ayushman Mitras, monthly training sessions soon
Beneficiaries eligible under the scheme can create their Ayushman card at any time throughout the year.
Eligible beneficiaries can either create the card themselves using Ayushman App or visit the nearest CSC or empanelled hospital to create their Ayushman card.
AB-PMJAY aims to provide health cover of Rs 5 lakh per family per year for secondary and tertiary care hospitalisation to approximately 55 crore beneficiaries corresponding to 12.34 crore families constituting the bottom 40 per cent of India’s population, according to official data.
Eligible beneficiaries can avail of cashless and paperless healthcare services related to hospitalisation across more than 29,000 empanelled hospitals in the country.
The cashless treatment covers all the costs related to treatment, medicines, supplies, diagnostic services, physician’s fees, room charges, surgeon charges, OT & ICU charges, etc.
The top speciality care treatments availed by beneficiaries to date are general medicine, infectious diseases, general surgery, medical oncology, ophthalmology and orthopaedics, according to the Health Ministry, IANS reported.
In the latest national master of the Health Benefit Package (HBP), the scheme provides cashless healthcare services related to 1,949 procedures across 27 medical specialities including General Medicine, Surgery, Cardiology, Oncology, etc.
Common procedures include hemodialysis, Covid-19 screening, and treatments for acute febrile illness.
The allocations for the PMJAY scheme in the Budget for 2024-25 allocation has been increased by 10 per cent to ₹7,300 crore from the revised estimate of ₹6,800 crore in 2023-24.
Overall, the Health Ministry's budget has been raised by 12.96 per cent to ₹90,958.63 crore, compared to ₹80,517.62 crore in the revised estimate for 2023-24.
As part of the healthcare package in the Budget, the government has also announced customs duty exemptions on three cancer treatment drugs -- Trastuzumab Deruxtecan, Osimertinib and Durvalumab. The move is aimed at reducing the cost of treatment for cancer patients.
Also Read:Delhi AIIMS directs to provide seamless healthcare services to AB-PMJAY beneficiaries
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!